Biologics for rheumatoid arthritis
48 results
1 - 48
Biologics for rheumatoid arthritis - Biologics for people with rheumatoid arthritis naive to methotrexate
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics
Biologics for rheumatoid arthritis: an overview of Cochrane reviews- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
- Rheumatoid arthritis
- Biologic interventions for fatigue in rheumatoid arthritis
- Abatacept for rheumatoid arthritis
- Golimumab for rheumatoid arthritis: Cochrane systematic review
- Tocilizumab for rheumatoid arthritis: Cochrane systematic review
- Anakinra for rheumatoid arthritis: Cochrane systematic review
- Juvenile idiopathic arthritis (juvenile rheumatoid arthritis)
- Rituximab for rheumatoid arthritis: Cochrane systematic review
- Abatacept for rheumatoid arthritis
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
- Combination therapy in rheumatoid arthritis
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
Zoster vaccine not associated with increased risk of HZ infection in immune-mediated disease patients- Adverse effects of biologics: a network meta‐analysis and Cochrane overview
- Antidepressants for pain management in rheumatoid arthritis: Cochrane systematic review
- Biologicals improve outcomes in patients with RA
- Tocilizumab for giant cell arteritis
- Chronic diseases and pregnancy